76 related articles for article (PubMed ID: 34358435)
1. Infection makes micro-CHIPs into macro-CHIPs.
Gopakumar J; Jaiswal S
Cell Stem Cell; 2021 Aug; 28(8):1335-1336. PubMed ID: 34358435
[TBL] [Abstract][Full Text] [Related]
2. Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling.
Hormaechea-Agulla D; Matatall KA; Le DT; Kain B; Long X; Kus P; Jaksik R; Challen GA; Kimmel M; King KY
Cell Stem Cell; 2021 Aug; 28(8):1428-1442.e6. PubMed ID: 33743191
[TBL] [Abstract][Full Text] [Related]
3. Dnmt3a-Mutant Hematopoietic Stem Cell Rewire IFNγ Signaling to Gain Clonal Advantage.
De Dominici M; DeGregori J
Blood Cancer Discov; 2022 May; 3(3):178-180. PubMed ID: 35394495
[TBL] [Abstract][Full Text] [Related]
4. Dnmt3a regulates myeloproliferation and liver-specific expansion of hematopoietic stem and progenitor cells.
Guryanova OA; Lieu YK; Garrett-Bakelman FE; Spitzer B; Glass JL; Shank K; Martinez AB; Rivera SA; Durham BH; Rapaport F; Keller MD; Pandey S; Bastian L; Tovbin D; Weinstein AR; Teruya-Feldstein J; Abdel-Wahab O; Santini V; Mason CE; Melnick AM; Mukherjee S; Levine RL
Leukemia; 2016 May; 30(5):1133-42. PubMed ID: 26710888
[TBL] [Abstract][Full Text] [Related]
5. Loss of Dnmt3a Immortalizes Hematopoietic Stem Cells In Vivo.
Jeong M; Park HJ; Celik H; Ostrander EL; Reyes JM; Guzman A; Rodriguez B; Lei Y; Lee Y; Ding L; Guryanova OA; Li W; Goodell MA; Challen GA
Cell Rep; 2018 Apr; 23(1):1-10. PubMed ID: 29617651
[TBL] [Abstract][Full Text] [Related]
6. Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation.
Mayle A; Yang L; Rodriguez B; Zhou T; Chang E; Curry CV; Challen GA; Li W; Wheeler D; Rebel VI; Goodell MA
Blood; 2015 Jan; 125(4):629-38. PubMed ID: 25416277
[TBL] [Abstract][Full Text] [Related]
7. miR-29a maintains mouse hematopoietic stem cell self-renewal by regulating Dnmt3a.
Hu W; Dooley J; Chung SS; Chandramohan D; Cimmino L; Mukherjee S; Mason CE; de Strooper B; Liston A; Park CY
Blood; 2015 Apr; 125(14):2206-16. PubMed ID: 25634742
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency for DNA methyltransferase 3A predisposes hematopoietic cells to myeloid malignancies.
Cole CB; Russler-Germain DA; Ketkar S; Verdoni AM; Smith AM; Bangert CV; Helton NM; Guo M; Klco JM; O'Laughlin S; Fronick C; Fulton R; Chang GS; Petti AA; Miller CA; Ley TJ
J Clin Invest; 2017 Oct; 127(10):3657-3674. PubMed ID: 28872462
[TBL] [Abstract][Full Text] [Related]
9. Base-Resolution Analysis of DNA Methylation Patterns Downstream of
Duncan CG; Kondilis-Mangum HD; Grimm SA; Bushel PR; Chrysovergis K; Roberts JD; Tyson FL; Merrick BA; Wade PA
G3 (Bethesda); 2018 Mar; 8(3):805-813. PubMed ID: 29326230
[TBL] [Abstract][Full Text] [Related]
10. De novo DNA methyltransferase is essential for self-renewal, but not for differentiation, in hematopoietic stem cells.
Tadokoro Y; Ema H; Okano M; Li E; Nakauchi H
J Exp Med; 2007 Apr; 204(4):715-22. PubMed ID: 17420264
[TBL] [Abstract][Full Text] [Related]
11. Sowing the Seeds of Clonal Hematopoiesis.
Liggett LA; Voit RA; Sankaran VG
Cell Stem Cell; 2020 Aug; 27(2):195-197. PubMed ID: 32763180
[TBL] [Abstract][Full Text] [Related]
12. Enhanc(er)ing Skin Stem Cells.
Wang Y; Sen GL
Cell Stem Cell; 2016 Oct; 19(4):415-417. PubMed ID: 27716517
[TBL] [Abstract][Full Text] [Related]
13. Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation.
Jacquelin S; Straube J; Cooper L; Vu T; Song A; Bywater M; Baxter E; Heidecker M; Wackrow B; Porter A; Ling V; Green J; Austin R; Kazakoff S; Waddell N; Hesson LB; Pimanda JE; Stegelmann F; Bullinger L; Döhner K; Rampal RK; Heckl D; Hill GR; Lane SW
Blood; 2018 Dec; 132(26):2707-2721. PubMed ID: 30366920
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic Insights into Cytosine-N3 Methylation by DNA Methyltransferase DNMT3A.
Dukatz M; Requena CE; Emperle M; Hajkova P; Sarkies P; Jeltsch A
J Mol Biol; 2019 Aug; 431(17):3139-3145. PubMed ID: 31229457
[TBL] [Abstract][Full Text] [Related]
15. De Novo DNA Methylation: Marking the Path from Stem Cell to Neural Fate.
Sawai A; Dasen JS
Cell Stem Cell; 2018 Apr; 22(4):469-471. PubMed ID: 29625060
[TBL] [Abstract][Full Text] [Related]
16. Myeloid disorders arise in Dnmt3a-null marrow.
Delwel R
Blood; 2015 Jan; 125(4):585-6. PubMed ID: 25614634
[No Abstract] [Full Text] [Related]
17. Enforced differentiation of Dnmt3a-null bone marrow leads to failure with c-Kit mutations driving leukemic transformation.
Celik H; Mallaney C; Kothari A; Ostrander EL; Eultgen E; Martens A; Miller CA; Hundal J; Klco JM; Challen GA
Blood; 2015 Jan; 125(4):619-28. PubMed ID: 25416276
[TBL] [Abstract][Full Text] [Related]
18. DNMT3L facilitates DNA methylation partly by maintaining DNMT3A stability in mouse embryonic stem cells.
Veland N; Lu Y; Hardikar S; Gaddis S; Zeng Y; Liu B; Estecio MR; Takata Y; Lin K; Tomida MW; Shen J; Saha D; Gowher H; Zhao H; Chen T
Nucleic Acids Res; 2019 Jan; 47(1):152-167. PubMed ID: 30321403
[TBL] [Abstract][Full Text] [Related]
19. Dnmt3a in the Medial Prefrontal Cortex Regulates Anxiety-Like Behavior in Adult Mice.
Elliott E; Manashirov S; Zwang R; Gil S; Tsoory M; Shemesh Y; Chen A
J Neurosci; 2016 Jan; 36(3):730-40. PubMed ID: 26791204
[TBL] [Abstract][Full Text] [Related]
20. Sequentially inducible mouse models reveal that Npm1 mutation causes malignant transformation of Dnmt3a-mutant clonal hematopoiesis.
Loberg MA; Bell RK; Goodwin LO; Eudy E; Miles LA; SanMiguel JM; Young K; Bergstrom DE; Levine RL; Schneider RK; Trowbridge JJ
Leukemia; 2019 Jul; 33(7):1635-1649. PubMed ID: 30692594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
